Orient Biotech(SH:688298) Xin Lang Cai Jing·2025-11-12 02:48Core Viewpoint - Oriental Bio's stock price has shown fluctuations, with a recent increase of 2.10% to 27.75 CNY per share, while the company has experienced a year-to-date decline of 5.39% [1] Financial Performance - For the period from January to September 2025, Oriental Bio reported a revenue of 672 million CNY, reflecting a year-on-year growth of 2.16% [2] - The company recorded a net profit attributable to shareholders of -213 million CNY, which is an improvement of 18.89% compared to the previous period [2] Shareholder Information - As of September 30, 2025, the number of shareholders for Oriental Bio was 13,300, a decrease of 3.93% from the previous period [2] - The average number of circulating shares per shareholder increased by 4.09% to 15,170 shares [2] Dividend Distribution - Since its A-share listing, Oriental Bio has distributed a total of 1.607 billion CNY in dividends, with 336 million CNY distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, the fourth largest circulating shareholder is Rongtong Health Industry Flexible Allocation Mixed A/B, holding 2.8 million shares, a decrease of 1.7001 million shares from the previous period [3] - Hong Kong Central Clearing Limited is the sixth largest shareholder, with 1.4675 million shares, an increase of 139,400 shares [3] - The Southern Science and Technology Innovation Board 3-Year Open Mixed Fund holds 780,900 shares, unchanged from the previous period [3]